Rob Dillard

Articles by Rob Dillard

Rob DillardSABCS 2024: Expert on Site | December 19, 2024
A study sought to assess if a treatment combination inhibits tumor growth and metastasis in TNBC.
Read More
Rob DillardSABCS 2024: Expert on Site | December 18, 2024
Sacituzumab govitecan-related neutropenia can be effectively treated using G-CSF prophylaxis in patients with mTNBC.
Rob DillardAHA 2024: CardioNerds | December 13, 2024
A study shows how how advancements in diagnostic tools and treatments for ATTR-CM have improved risk profiles.
Rob DillardAHA 2024: CardioNerds | December 13, 2024
A recent post-hoc analysis of the ATTRibute-CM trial shows the potential for acoramidis in treating ATTR-CM.
Rob DillardAHA 2024 | December 13, 2024
A study found an overall decline in surgical myectomy with ICD procedures since 2016.
Rob DillardOrthopedics | December 12, 2024
Mobile device-based 3D scanning identifies clinically relevant adolescent idiopathic scoliosis deformity.
Rob DillardSABCS 2024 | December 12, 2024
Researchers sought to assess the rate of axillary pCR in TNBC patients.
Rob DillardSABCS 2024 | December 12, 2024
Adding pembrolizumab to conventional neoadjuvant cytotoxic chemotherapy may improve survival outcomes.
Rob DillardSABCS 2024 | December 12, 2024
Researchers assessed the real-world treatment patterns and clinical outcomes of HER+ BC brain metastases.
Rob DillardSABCS 2024 | December 11, 2024
Individuals with metaplastic breast cancer (MpBC) show a distinct molecular phenotype.
Rob DillardSABCS 2024 | December 11, 2024
A study sought to characterize the molecular and immunological features of the androgen receptor in male breast cancer.
Rob DillardSABCS 2024 | December 11, 2024
People with hereditary cancer pathogenic variants for breast cancer may elect to undergo bilateral mastectomy for prevention.
Rob DillardSABCS 2024 | December 10, 2024
The combination of tucatinib and alpelisib is both tolerable and effective at treating patients with HER2-positive MBC.
Rob DillardCareer News | December 4, 2024
The CEO of UnitedHealthcare's insurance division was gunned down in Midtown in what police are calling a targeted attack.
Rob DillardUrology | December 3, 2024
Transcutaneous tibial nerve stimulation is a clinically effective treatment for overactive bladder symptoms.
Rob DillardAHA 2024 | December 3, 2024
A new study shows that progression from low burden atrial fibrillation (AF) is associated with negative outcomes.
Rob DillardAHA 2024 | December 3, 2024
Individuals with cardiac implantable electronic devices have a higher risk of tricuspid regurgitation.
Rob DillardAHA 2024: CardioNerds | November 27, 2024
The U.S. FDA recently approved Attruby (acoramidis) for adults with ATTR-CM to reduce cardiovascular death, hospitalization.
Rob DillardAHA 2024: CardioNerds | November 26, 2024
A case study highlights the importance of avoiding anchoring bias in the diagnosis of cardiac amyloidosis.
Rob DillardAHA 2024: CardioNerds | November 26, 2024
The diagnosis of AL amyloidosis requires a high index of suspicion to render a prompt diagnosis and appropriate treatment.